Palatin Technologies Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.01
- Today's High:
- $2.05
- Open Price:
- $2.05
- 52W Low:
- $1.82
- 52W High:
- $8.6
- Prev. Close:
- $2.01
- Volume:
- 58890
Company Statistics
- Market Cap.:
- $23.16 million
- Book Value:
- 0.86
- Revenue TTM:
- $3.86 million
- Operating Margin TTM:
- -926.07%
- Gross Profit TTM:
- $-20076506
- Profit Margin:
- 0%
- Return on Assets TTM:
- -64.4%
- Return on Equity TTM:
- -157.1%
Company Profile
Palatin Technologies Inc had its IPO on 1993-10-28 under the ticker symbol PTN.
The company operates in the Healthcare sector and Biotechnology industry. Palatin Technologies Inc has a staff strength of 33 employees.
Stock update
Shares of Palatin Technologies Inc opened at $2.05 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.01 - $2.05, and closed at $2.01.
This is a 0% increase from the previous day's closing price.
A total volume of 58,890 shares were traded at the close of the day’s session.
In the last one week, shares of Palatin Technologies Inc have slipped by -4.74%.
Palatin Technologies Inc's Key Ratios
Palatin Technologies Inc has a market cap of $23.16 million, indicating a price to book ratio of 4.2522 and a price to sales ratio of 15.6832.
In the last 12-months Palatin Technologies Inc’s revenue was $3.86 million with a gross profit of $-20076506 and an EBITDA of $-35519496. The EBITDA ratio measures Palatin Technologies Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Palatin Technologies Inc’s operating margin was -926.07% while its return on assets stood at -64.4% with a return of equity of -157.1%.
In Q1, Palatin Technologies Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 453.3%.
Palatin Technologies Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-2.71 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Palatin Technologies Inc’s profitability.
Palatin Technologies Inc stock is trading at a EV to sales ratio of 7.2402 and a EV to EBITDA ratio of -0.4248. Its price to sales ratio in the trailing 12-months stood at 15.6832.
Palatin Technologies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $25.61 million
- Total Liabilities
- $11.85 million
- Operating Cash Flow
- $-381530.00
- Capital Expenditure
- $116875
- Dividend Payout Ratio
- 0%
Palatin Technologies Inc ended 2024 with $25.61 million in total assets and $0 in total liabilities. Its intangible assets were valued at $25.61 million while shareholder equity stood at $9.59 million.
Palatin Technologies Inc ended 2024 with $0 in deferred long-term liabilities, $11.85 million in other current liabilities, 111527.00 in common stock, $-404821120.00 in retained earnings and $0 in goodwill. Its cash balance stood at $19.63 million and cash and short-term investments were $19.63 million. The company’s total short-term debt was $406,167 while long-term debt stood at $0.
Palatin Technologies Inc’s total current assets stands at $24.24 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.70 million compared to accounts payable of $2.79 million and inventory worth $630033.00.
In 2024, Palatin Technologies Inc's operating cash flow was $-381530.00 while its capital expenditure stood at $116875.
Comparatively, Palatin Technologies Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $2.01
- 52-Week High
- $8.6
- 52-Week Low
- $1.82
- Analyst Target Price
- $43
Palatin Technologies Inc stock is currently trading at $2.01 per share. It touched a 52-week high of $8.6 and a 52-week low of $8.6. Analysts tracking the stock have a 12-month average target price of $43.
Its 50-day moving average was $2.22 and 200-day moving average was $2.75 The short ratio stood at 2.9 indicating a short percent outstanding of 0%.
Around 657.9% of the company’s stock are held by insiders while 1971.2% are held by institutions.
Frequently Asked Questions About Palatin Technologies Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.